Evidence map›Paper›PMID 41886018›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2026

n-Hexane-Toxic Neuropathy Presenting with Cauda Equina Inflammation.

Rika Nohara, Hiroya Kuwahara, Honami Kawai, Tatsuhiko Sano, Kinya Ishikawa, Takashi Kanda, Yoichiro Nishida

Abstract readCase Reports
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rika NoharaDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan.
Hiroya KuwaharaDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan. h-kuwahara.nuro@tmd.ac.jp.ORCID http://orcid.org/0009-0001-7735-1963
Honami KawaiDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan.
Tatsuhiko SanoDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan.
Kinya IshikawaDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan.
Takashi KandaDepartment of Neurology, Neuromuscular Center Yoshimizu Hospital, Shimonoseki, Japan.
Yoichiro NishidaDepartment of Neurology and Neurological Science, Institute of Science Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHabitual exposure to n-hexane can cause polyneuropathy through axonal degeneration and secondary demyelination. To our knowledge, n-hexane-toxic neuropathy presenting with a cauda equina-like syndrome has not previously been reported. CASE PRESENTATION: A 55-year-old man developed sensory and motor polyneuropathy over a 3-month period, with nerve conduction studies indicating demyelination. Initial treatment for suspected chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with steroids and plasma exchange was ineffective, leading to worsening symptoms. The patient and his colleagues were found to have been habitually exposed to n-hexane in their printing work, and a sural nerve biopsy revealed the pathological findings typical of n-hexane-toxic neuropathy. Notably, cauda equina inflammation was observed on MRI and in the cerebrospinal fluid. Following intravenous immunoglobulin therapy, both neurological symptoms and findings from nerve conduction studies, MRI, and cerebrospinal fluid analysis gradually improved, eventually leading the absence of impairment in activities of daily living.

conclusionIn cases of polyneuropathy accompanied by inflammation of the cauda equina, and if exposure to n-hexane cannot be ruled out, sural nerve biopsy could be considered to assess for n-hexane-toxic neuropathy.

Indexed as

Cauda EquinaCauda Equina SyndromeHexanesBiopsyHumansImmunoglobulins, IntravenousMagnetic Resonance ImagingMaleMiddle AgedNerve Conduction StudiesNeural ConductionSural NerveTreatment OutcomeHexanesImmunoglobulins, Intravenousn-hexane2,5-hexanedioneCauda equina inflammationn-hexane-toxic neuropathy

Identifiers

PMID41886018
PMCPMC13076710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.